These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells. Banerjee A; Qian P; Wu ZS; Ren X; Steiner M; Bougen NM; Liu S; Liu DX; Zhu T; Lobie PE J Biol Chem; 2012 Dec; 287(51):42502-15. PubMed ID: 23095743 [TBL] [Abstract][Full Text] [Related]
4. Tumor-Induced Generation of Splenic Erythroblast-like Ter-Cells Promotes Tumor Progression. Han Y; Liu Q; Hou J; Gu Y; Zhang Y; Chen Z; Fan J; Zhou W; Qiu S; Zhang Y; Dong T; Li N; Jiang Z; Zhu H; Zhang Q; Ma Y; Zhang L; Wang Q; Yu Y; Li N; Cao X Cell; 2018 Apr; 173(3):634-648.e12. PubMed ID: 29606356 [TBL] [Abstract][Full Text] [Related]
5. Artemin and an Artemin-Derived Peptide, Artefin, Induce Neuronal Survival, and Differentiation Through Ret and NCAM. Ilieva M; Nielsen J; Korshunova I; Gotfryd K; Bock E; Pankratova S; Michel TM Front Mol Neurosci; 2019; 12():47. PubMed ID: 30853893 [TBL] [Abstract][Full Text] [Related]
7. The role of glial cell line-derived neurotrophic factor family member artemin in neurological disorders and cancers. Zhu S; Li Y; Bennett S; Chen J; Weng IZ; Huang L; Xu H; Xu J Cell Prolif; 2020 Jul; 53(7):e12860. PubMed ID: 32573073 [TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of the expression of GFRα1, GFRα3 and syndecan-3, proteins binding ARTEMIN, in mammary carcinoma. Wu ZS; Pandey V; Wu WY; Ye S; Zhu T; Lobie PE BMC Cancer; 2013 Jan; 13():34. PubMed ID: 23351331 [TBL] [Abstract][Full Text] [Related]
9. Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice. Deng L; Liang H; Burnette B; Beckett M; Darga T; Weichselbaum RR; Fu YX J Clin Invest; 2014 Feb; 124(2):687-95. PubMed ID: 24382348 [TBL] [Abstract][Full Text] [Related]
10. Elimination of tumor by CD47/PD-L1 dual-targeting fusion protein that engages innate and adaptive immune responses. Liu B; Guo H; Xu J; Qin T; Guo Q; Gu N; Zhang D; Qian W; Dai J; Hou S; Wang H; Guo Y MAbs; 2018; 10(2):315-324. PubMed ID: 29182441 [TBL] [Abstract][Full Text] [Related]
11. Artemin-stimulated progression of human non-small cell lung carcinoma is mediated by BCL2. Tang JZ; Kong XJ; Kang J; Fielder GC; Steiner M; Perry JK; Wu ZS; Yin Z; Zhu T; Liu DX; Lobie PE Mol Cancer Ther; 2010 Jun; 9(6):1697-708. PubMed ID: 20530713 [TBL] [Abstract][Full Text] [Related]
12. Artemin is hypoxia responsive and promotes oncogenicity and increased tumor initiating capacity in hepatocellular carcinoma. Zhang M; Zhang W; Wu Z; Liu S; Sun L; Zhong Y; Zhang X; Kong X; Qian P; Zhang H; Lobie PE; Zhu T Oncotarget; 2016 Jan; 7(3):3267-82. PubMed ID: 26675549 [TBL] [Abstract][Full Text] [Related]
13. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer. Ji D; Song C; Li Y; Xia J; Wu Y; Jia J; Cui X; Yu S; Gu J J Immunother Cancer; 2020 Oct; 8(2):. PubMed ID: 33106387 [TBL] [Abstract][Full Text] [Related]
14. α-PD-L1 mAb enhances the abscopal effect of hypo-fractionated radiation by attenuating PD-L1 expression and inducing CD8 Wang H; Lin X; Luo Y; Sun S; Tian X; Sun Y; Zhang S; Chen J; Zhang J; Liu X; Liu H; Gong Y; Xie C Immunotherapy; 2019 Feb; 11(2):101-118. PubMed ID: 30511887 [TBL] [Abstract][Full Text] [Related]
15. ARTEMIN promotes de novo angiogenesis in ER negative mammary carcinoma through activation of TWIST1-VEGF-A signalling. Banerjee A; Wu ZS; Qian PX; Kang J; Liu DX; Zhu T; Lobie PE PLoS One; 2012; 7(11):e50098. PubMed ID: 23185544 [TBL] [Abstract][Full Text] [Related]
17. Antidepressant-like effect of artemin in mice: a mechanism for acetyl-L-carnitine activity on depression. Di Cesare Mannelli L; Vivoli E; Salvicchi A; Schiavone N; Koverech A; Messano M; Nicolai R; Benatti P; Bartolini A; Ghelardini C Psychopharmacology (Berl); 2011 Nov; 218(2):347-56. PubMed ID: 21590285 [TBL] [Abstract][Full Text] [Related]
18. Targeting interferon signaling and CTLA-4 enhance the therapeutic efficacy of anti-PD-1 immunotherapy in preclinical model of HPV Dorta-Estremera S; Hegde VL; Slay RB; Sun R; Yanamandra AV; Nicholas C; Nookala S; Sierra G; Curran MA; Sastry KJ J Immunother Cancer; 2019 Sep; 7(1):252. PubMed ID: 31533840 [TBL] [Abstract][Full Text] [Related]
19. Artemin, a member of the glial cell line-derived neurotrophic factor family of ligands, is HER2-regulated and mediates acquired trastuzumab resistance by promoting cancer stem cell-like behavior in mammary carcinoma cells. Ding K; Banerjee A; Tan S; Zhao J; Zhuang Q; Li R; Qian P; Liu S; Wu ZS; Lobie PE; Zhu T J Biol Chem; 2014 Jun; 289(23):16057-71. PubMed ID: 24737320 [TBL] [Abstract][Full Text] [Related]
20. ARTEMIN synergizes with TWIST1 to promote metastasis and poor survival outcome in patients with ER negative mammary carcinoma. Banerjee A; Wu ZS; Qian P; Kang J; Pandey V; Liu DX; Zhu T; Lobie PE Breast Cancer Res; 2011; 13(6):R112. PubMed ID: 22060274 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]